8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-15-059259
Material agreement · Results of operations · Unregistered share sale · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
- Item 3.02 Unregistered sales of equity securities
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading v422102_8-k.htm…